JP7311424B2 - 糖尿病循環合併症を査定するためのシステムおよび方法 - Google Patents
糖尿病循環合併症を査定するためのシステムおよび方法 Download PDFInfo
- Publication number
- JP7311424B2 JP7311424B2 JP2019551600A JP2019551600A JP7311424B2 JP 7311424 B2 JP7311424 B2 JP 7311424B2 JP 2019551600 A JP2019551600 A JP 2019551600A JP 2019551600 A JP2019551600 A JP 2019551600A JP 7311424 B2 JP7311424 B2 JP 7311424B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- light
- diabetes
- present disclosure
- detector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims description 94
- 238000000034 method Methods 0.000 title claims description 70
- 238000005259 measurement Methods 0.000 claims description 54
- 230000003287 optical effect Effects 0.000 claims description 54
- 238000003384 imaging method Methods 0.000 claims description 40
- 230000006438 vascular health Effects 0.000 claims description 36
- 102000001554 Hemoglobins Human genes 0.000 claims description 32
- 108010054147 Hemoglobins Proteins 0.000 claims description 32
- 238000005286 illumination Methods 0.000 claims description 24
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 21
- 239000001301 oxygen Substances 0.000 claims description 21
- 238000003745 diagnosis Methods 0.000 claims description 15
- 230000036541 health Effects 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 12
- 230000006378 damage Effects 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 10
- 238000012986 modification Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 238000002560 therapeutic procedure Methods 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- 230000000750 progressive effect Effects 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 230000002596 correlated effect Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 152
- 208000025865 Ulcer Diseases 0.000 description 35
- 238000009826 distribution Methods 0.000 description 30
- 208000018262 Peripheral vascular disease Diseases 0.000 description 26
- 230000004087 circulation Effects 0.000 description 26
- 230000010412 perfusion Effects 0.000 description 24
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 22
- 238000010521 absorption reaction Methods 0.000 description 22
- 101100366935 Caenorhabditis elegans sto-2 gene Proteins 0.000 description 21
- 231100000397 ulcer Toxicity 0.000 description 21
- 239000000523 sample Substances 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 230000036269 ulceration Effects 0.000 description 14
- 230000002792 vascular Effects 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 12
- 206010040030 Sensory loss Diseases 0.000 description 12
- 210000004207 dermis Anatomy 0.000 description 12
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000001747 exhibiting effect Effects 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 238000006213 oxygenation reaction Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 206010020649 Hyperkeratosis Diseases 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 230000009257 reactivity Effects 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 7
- 208000019553 vascular disease Diseases 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 210000002565 arteriole Anatomy 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 210000000264 venule Anatomy 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000036571 hydration Effects 0.000 description 5
- 238000006703 hydration reaction Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000037816 tissue injury Diseases 0.000 description 4
- 230000001457 vasomotor Effects 0.000 description 4
- 206010009192 Circulatory collapse Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000002051 biphasic effect Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 230000001010 compromised effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 238000002647 laser therapy Methods 0.000 description 3
- 201000001119 neuropathy Diseases 0.000 description 3
- 230000007823 neuropathy Effects 0.000 description 3
- 208000033808 peripheral neuropathy Diseases 0.000 description 3
- 206010040560 shock Diseases 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000000287 tissue oxygenation Effects 0.000 description 3
- 206010065929 Cardiovascular insufficiency Diseases 0.000 description 2
- 208000008960 Diabetic foot Diseases 0.000 description 2
- 238000000342 Monte Carlo simulation Methods 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000002981 neuropathic effect Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229940025703 topical product Drugs 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000019028 Epidermal thickening Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000022064 reactive hyperemia Diseases 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/447—Skin evaluation, e.g. for skin disorder diagnosis specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0064—Body surface scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/486—Biofeedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/7425—Displaying combinations of multiple images regardless of image source, e.g. displaying a reference anatomical image with a live image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
- A61B5/748—Selection of a region of interest, e.g. using a graphics tablet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/22—Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
- A61B2562/221—Arrangements of sensors with cables or leads, e.g. cable harnesses
- A61B2562/223—Optical cables therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0073—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by tomography, i.e. reconstruction of 3D images from 2D projections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02042—Determining blood loss or bleeding, e.g. during a surgical procedure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762475059P | 2017-03-22 | 2017-03-22 | |
| US62/475,059 | 2017-03-22 | ||
| PCT/US2018/023856 WO2018175787A1 (en) | 2017-03-22 | 2018-03-22 | Method and apparatus for assessing diabetic circulatory complications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512852A JP2020512852A (ja) | 2020-04-30 |
| JP2020512852A5 JP2020512852A5 (enExample) | 2021-04-30 |
| JP7311424B2 true JP7311424B2 (ja) | 2023-07-19 |
Family
ID=63585758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551600A Active JP7311424B2 (ja) | 2017-03-22 | 2018-03-22 | 糖尿病循環合併症を査定するためのシステムおよび方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11751769B2 (enExample) |
| EP (1) | EP3573521B1 (enExample) |
| JP (1) | JP7311424B2 (enExample) |
| KR (1) | KR102597974B1 (enExample) |
| CN (1) | CN110573064B (enExample) |
| CA (1) | CA3055768A1 (enExample) |
| SG (1) | SG11201908706QA (enExample) |
| TW (1) | TWI801370B (enExample) |
| WO (1) | WO2018175787A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3106626A1 (en) | 2018-07-16 | 2020-01-23 | Bbi Medical Innovations, Llc | Perfusion and oxygenation measurement |
| EP3866675A4 (en) * | 2018-10-15 | 2022-07-06 | Podimetrics, Inc. | IPSILATERAL ULCER AND METHODS AND DEVICE FOR DETECTING PRE-ULCERATIONS |
| CN111265188A (zh) * | 2020-01-21 | 2020-06-12 | 温州医科大学 | 一种基于局部微循环的糖尿病足风险评估装置及方法 |
| KR102535884B1 (ko) | 2020-05-06 | 2023-05-24 | 고려대학교 산학협력단 | 당뇨병성 합병증 모니터링 장치 및 이를 이용하는 당뇨병성 합병증 관리 시스템 |
| US12419521B2 (en) | 2020-08-21 | 2025-09-23 | Empo Health, Inc. | System to detect foot abnormalities |
| TWI758219B (zh) * | 2021-08-10 | 2022-03-11 | 國立臺灣科技大學 | 遠紅外線的生物效應的評估方法 |
| CN113974580A (zh) * | 2021-10-29 | 2022-01-28 | 苏州爱琴生物医疗电子有限公司 | 一种基于nirs技术的颈动脉狭窄程度分析方法 |
| CA3238042A1 (en) | 2021-12-06 | 2023-06-15 | Podimetrics, Inc. | Apparatus and method of measuring blood flow in the foot |
| KR102781515B1 (ko) * | 2022-04-08 | 2025-03-14 | (주)파인헬스케어 | 병원에서 욕창 상태를 결정하고 치료하기 위한 장치 및 장치의 동작 방법 |
| KR102780364B1 (ko) * | 2022-06-28 | 2025-03-12 | 계명대학교 산학협력단 | 모바일 카메라로 혈류의 양을 측정하여 욕창을 진단할 수 있는 인공지능 기반 욕창 진단 장치 및 시스템 |
| US20240081682A1 (en) * | 2022-09-14 | 2024-03-14 | Hbt Co., Ltd. | System for diagnosing a foot condition by scanning the foot and a method for diagnosing the foot condition using the same |
| EP4618828A1 (en) * | 2022-11-15 | 2025-09-24 | Biotronik Ag | An ai based system for monitoring of peripheral vascular disease patients |
| CN116671997A (zh) * | 2023-05-30 | 2023-09-01 | 无锡海斯凯尔医学技术有限公司 | 组织旋切路径的确定方法、装置及可读存储介质 |
| CN116831528A (zh) * | 2023-06-29 | 2023-10-03 | 北京理工大学 | 一种基于高光谱重建的多尺度信息融合的糖尿病足预测方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013202303A (ja) | 2012-03-29 | 2013-10-07 | Hiroshi Oda | 磁気治療器 |
| US20150265195A1 (en) | 2014-03-21 | 2015-09-24 | Mark Anthony Darty | Systems and methods for measuring tissue oxygenation |
| JP2015533429A (ja) | 2012-11-07 | 2015-11-24 | モデュレイテッド イメージング， インコーポレイテッド | 効率的変調撮像 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1272101A2 (en) * | 2000-04-13 | 2003-01-08 | National Research Council of Canada Ltd. | Tissue viability/health monitor utilizing near infrared spectroscopy |
| NZ527164A (en) * | 2001-01-26 | 2005-07-29 | Sensys Medical Inc | Noninvasive measurement of glucose through the optical properties of tissue |
| US7920908B2 (en) * | 2003-10-16 | 2011-04-05 | David Hattery | Multispectral imaging for quantitative contrast of functional and structural features of layers inside optically dense media such as tissue |
| US8548570B2 (en) * | 2004-11-29 | 2013-10-01 | Hypermed Imaging, Inc. | Hyperspectral imaging of angiogenesis |
| US8374682B2 (en) * | 2005-04-04 | 2013-02-12 | Hypermed Imaging, Inc. | Hyperspectral imaging in diabetes and peripheral vascular disease |
| CA2592691C (en) * | 2004-12-28 | 2017-07-04 | Hypermed, Inc. | Hyperspectral/multispectral imaging in determination, assessment and monitoring of systemic physiology and shock |
| US8971984B2 (en) * | 2005-04-04 | 2015-03-03 | Hypermed Imaging, Inc. | Hyperspectral technology for assessing and treating diabetic foot and tissue disease |
| US8644911B1 (en) * | 2006-06-30 | 2014-02-04 | Hypermed Imaging, Inc. | OxyVu-1 hyperspectral tissue oxygenation (HTO) measurement system |
| US8116838B2 (en) * | 2007-11-27 | 2012-02-14 | Carnegie Mellon University | Medical device for diagnosing pressure ulcers |
| US20100210931A1 (en) * | 2008-04-04 | 2010-08-19 | Modulate Imaging Inc. | Method for performing qualitative and quantitative analysis of wounds using spatially structured illumination |
| US8812083B2 (en) * | 2008-04-21 | 2014-08-19 | Philadelphia Health & Education Corporation | Methods of optically monitoring wound healing |
| US20100312076A1 (en) * | 2009-06-03 | 2010-12-09 | Bly Deborah C | Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof |
| WO2011063306A1 (en) | 2009-11-19 | 2011-05-26 | Modulated Imaging Inc. | Method and apparatus for analysis of turbid media via single-element detection using structured illumination |
| WO2012075126A2 (en) * | 2010-11-30 | 2012-06-07 | The Board Of Regents Of The University Of Texas System | Methods and apparatus related to photothermal optical coherence tomography (oct) |
| EP2691016B1 (en) * | 2011-03-31 | 2021-08-25 | Aarhus Universitet | System for assessing tissue substance extraction |
| US8868157B1 (en) * | 2011-11-09 | 2014-10-21 | VisionQuest Biomedical LLC | Thermal optical imager system and method for detection of peripheral neuropathy |
| US20140213910A1 (en) * | 2013-01-25 | 2014-07-31 | The Regents Of The University Of California | Method and apparatus for performing qualitative and quantitative analysis of burn extent and severity using spatially structured illumination |
| US20140276014A1 (en) * | 2013-03-13 | 2014-09-18 | Cephalogics, LLC | Supports for optical sensors and related apparatus and methods |
| US9655519B2 (en) * | 2014-03-21 | 2017-05-23 | Hypermed Imaging, Inc. | Systems and methods for performing an imaging test under constrained conditions |
| US20150327777A1 (en) * | 2014-05-14 | 2015-11-19 | Stryker Corporation | Tissue monitoring apparatus and system |
| AU2015277218B2 (en) * | 2014-06-18 | 2021-02-25 | Innopix, Inc. | Spectral imaging system for remote and noninvasive detection of target substances using spectral filter arrays and image capture arrays |
| SG11201806813XA (en) | 2016-02-12 | 2018-09-27 | Modulated Imaging Inc | Method and apparatus for assessing tissue vascular health |
-
2018
- 2018-03-22 WO PCT/US2018/023856 patent/WO2018175787A1/en not_active Ceased
- 2018-03-22 JP JP2019551600A patent/JP7311424B2/ja active Active
- 2018-03-22 TW TW107109908A patent/TWI801370B/zh active
- 2018-03-22 KR KR1020197031098A patent/KR102597974B1/ko active Active
- 2018-03-22 CN CN201880019801.9A patent/CN110573064B/zh active Active
- 2018-03-22 SG SG11201908706Q patent/SG11201908706QA/en unknown
- 2018-03-22 EP EP18771715.2A patent/EP3573521B1/en active Active
- 2018-03-22 CA CA3055768A patent/CA3055768A1/en active Pending
-
2019
- 2019-09-09 US US16/565,045 patent/US11751769B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013202303A (ja) | 2012-03-29 | 2013-10-07 | Hiroshi Oda | 磁気治療器 |
| JP2015533429A (ja) | 2012-11-07 | 2015-11-24 | モデュレイテッド イメージング， インコーポレイテッド | 効率的変調撮像 |
| US20150265195A1 (en) | 2014-03-21 | 2015-09-24 | Mark Anthony Darty | Systems and methods for measuring tissue oxygenation |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190133026A (ko) | 2019-11-29 |
| EP3573521A1 (en) | 2019-12-04 |
| TWI801370B (zh) | 2023-05-11 |
| SG11201908706QA (en) | 2019-10-30 |
| WO2018175787A1 (en) | 2018-09-27 |
| CN110573064B (zh) | 2023-01-06 |
| US20200107732A1 (en) | 2020-04-09 |
| KR102597974B1 (ko) | 2023-11-02 |
| TW201839379A (zh) | 2018-11-01 |
| CA3055768A1 (en) | 2018-09-27 |
| US11751769B2 (en) | 2023-09-12 |
| JP2020512852A (ja) | 2020-04-30 |
| CN110573064A (zh) | 2019-12-13 |
| EP3573521B1 (en) | 2022-12-28 |
| EP3573521A4 (en) | 2020-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7311424B2 (ja) | 糖尿病循環合併症を査定するためのシステムおよび方法 | |
| JP7045999B2 (ja) | 組織血管健康を評価するための方法および装置 | |
| Moço et al. | New insights into the origin of remote PPG signals in visible light and infrared | |
| US9254220B1 (en) | Method and system for assessing severity and stage of peripheral arterial disease and lower extremity wounds using angiosome mapping | |
| Weinkauf et al. | Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment | |
| EP4262531A1 (en) | System and method for monitoring blood perfusion | |
| Bergkvist et al. | Assessment of microcirculation of the skin using Tissue Viability Imaging: A promising technique for detecting venous stasis in the skin | |
| CN111265188A (zh) | 一种基于局部微循环的糖尿病足风险评估装置及方法 | |
| Li et al. | A reflectance model for non-contact mapping of venous oxygen saturation using a CCD camera | |
| US11950848B2 (en) | Fundus imaging for microvascular assessment | |
| Akimbekov et al. | An Overview of Quantitative Capillary Refill Time: Measurement and Application in Clinical Practice | |
| HK40019747B (en) | Systems and methods for assessing diabetic circulatory complications | |
| Zhang et al. | Convenient prediction of TcPO2 level using machine learning techniques with the PPG signal’s characteristic features | |
| HK40019747A (en) | Systems and methods for assessing diabetic circulatory complications | |
| HK40002629B (en) | Method and apparatus for assessing tissue vascular health | |
| HK40002629A (en) | Method and apparatus for assessing tissue vascular health | |
| Varaki et al. | Arterial and venous peripheral vascular assessment using wearable electro-resistive morphic sensors | |
| Harrison | NOVEL NONINVASIVE OPTICAL DIAGNOSTIC TECHNOLOGIES FOR THE MANAGEMENT OF NEONATAL JAUNDICE | |
| Hinssen et al. | Functional venous diagnostics: spatial acquisition of hemodynamic behavior during muscle pump tests |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210317 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210317 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220209 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220311 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220610 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220810 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220912 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221214 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230414 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20230414 |
|
| C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20230425 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20230511 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230704 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230706 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7311424 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |